You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 76 No. 4, OCTOBER 1945 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (27)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

NEUROLOGIC COMPLICATIONS DURING MENINGOCOCCIC MENINGITIS TREATED WITH SULFONAMIDE DRUGS

LIEUTENANT THOMAS W. FARMER, MC-S, U.S.N.R.

Arch Intern Med. 1945;76(4):201-209.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The purpose of this presentation is to outline the clinical course and prognosis in a variety of neurologic complications of meningococcic meningitis. During the epidemic years of 1942, 1943 and 1944, approximately 300 cases of meningococcic meningitis were reviewed by me at four hospitals.1 About 100 cases involving children were included in this series. Of the 300 cases focal neurologic complications were observed to develop in 26 during the course of meningococcic infections. In each of these 26 cases it was ascertained that the paralysis did not exist before the onset of the meningeal infection and also that no other neurologic disease was present concomitantly with the meningitis. Detailed clinical information concerning the onset and severity of these sequelae was collected for this study.

An etiologic diagnosis was established in 24 of these 26 cases by the isolation of meningococci, group I, from the cerebrospinal fluid. In the remaining . . . [Full Text PDF of this Article]


Footnotes

This article has been released for publication by the Division of Publications of the Bureau of Medicine and Surgery of the United States Navy. The opinions and views set forth are those of the writer and are not to be construed as reflecting the policies of the Navy Department.

Formerly from the Biological Division, Medical Clinic, the School of Medicine, Johns Hopkins University and Hospital.

Dr. Derek Denny-Brown, Dr. Conrad Wesselhoeft and Dr. George Thorn, the chiefs of service at these hospitals, gave permission for the presentation of these cases.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1945 American Medical Association. All Rights Reserved.